DSIP: Delta Sleep Inducing Peptide
A 9-amino acid neuropeptide naturally found in the brain, studied for sleep regulation, stress modulation, and neuroendocrine effects.
Quick Reference
| Research Dosage | 100-300mcg before sleep |
|---|---|
| Frequency | Once daily (evening) |
| Administration | Subcutaneous or intramuscular |
| Cycle Length | 2-4 weeks typical |
| Reconstitution | 2mL bacteriostatic water per 5mg vial |
| Storage | Refrigerate after reconstitution, use within 3 weeks |
DSIP holds a unique place in peptide research history – it was one of the first sleep-regulating substances ever isolated from the brain. Discovered in 1974 by Swiss researchers Marcel Monnier and colleagues, DSIP was identified through an elegant experiment: they found they could transfer sleepiness from one rabbit to another using a peptide isolated from the sleeping animal's brain.
Named for its ability to promote delta wave sleep – the deepest, most restorative phase characterised by slow brain waves – DSIP has since been found to affect far more than just sleep. Research has documented effects on stress hormones, pain perception, body temperature, and various neuroendocrine functions.
What makes DSIP particularly fascinating from a scientific perspective is that despite decades of research, its mechanism remains incompletely understood. Unlike most bioactive peptides with clearly identified receptor targets, DSIP's receptor(s) have never been definitively characterised. This mystery, combined with its documented biological effects, continues to drive research interest.
Research Applications
DSIP is studied across multiple domains of neuroscience, sleep medicine, and endocrinology:
Sleep Research
Delta Wave (Slow-Wave) Sleep Promotion
DSIP's namesake effect involves promoting delta wave activity:
- Delta waves (0.5-4 Hz) characterise the deepest sleep stage (N3/slow-wave sleep)
- This phase is critical for physical restoration, immune function, and memory consolidation
- Research shows DSIP increases delta wave activity on EEG recordings
- May improve overall sleep architecture without causing sedation
Sleep Onset and Continuity
Studies have examined DSIP's effects on:
- Sleep latency (time to fall asleep)
- Sleep continuity (reduced awakenings)
- Total sleep time
- Sleep efficiency (time asleep vs. time in bed)
Circadian Rhythm Research
DSIP research extends to chronobiology:
- May help resynchronise disrupted circadian rhythms
- Studied in shift work and jet lag contexts
- Potential role in circadian clock mechanisms
- Effects on melatonin and other circadian hormones
Sleep Disorder Research
DSIP has been investigated in various sleep disturbances:
- Insomnia (primary and secondary)
- Chronic fatigue conditions
- Disrupted sleep architecture
- Age-related sleep changes
Stress and Cortisol Research
HPA Axis Modulation
DSIP significantly affects the hypothalamic-pituitary-adrenal axis:
- Modulates CRH (corticotropin-releasing hormone) activity
- Affects ACTH release patterns
- Influences cortisol secretion and rhythms
- May help normalise disrupted stress hormone patterns
Chronic Stress Research
Studies have examined whether DSIP helps with stress adaptation:
- Chronic stress models
- Stress-induced physiological changes
- Recovery from stress exposure
- Stress resilience
Cortisol Pattern Normalisation
Of particular interest is DSIP's potential to normalise abnormal cortisol patterns:
- Flattened cortisol rhythms
- Elevated evening cortisol
- Stress-induced cortisol dysregulation
Pain Research
Analgesic Properties
Research has documented pain-modulating effects:
- Reduces pain perception in various models
- May enhance endogenous opioid effects
- Studied in chronic pain contexts
- Affects pain thresholds
Opioid System Interactions
Studies have examined DSIP's interactions with the opioid system:
- May potentiate opioid analgesia
- Possible role in reducing opioid tolerance development
- Research in opioid withdrawal contexts
- Enkephalin system modulation
Neuroendocrine Research
Growth Hormone
Some studies have reported DSIP effects on GH release:
- May influence nocturnal GH secretion patterns
- GH is primarily released during deep sleep
- DSIP's sleep effects may indirectly affect GH
- Relevant to somatotropic axis research
Thyroid Function
Research has examined effects on thyroid hormones:
- TSH modulation reported in some studies
- Possible effects on T3/T4
- Metabolic implications
Dosage Information
Standard Research Dosages
Dosages commonly referenced in literature range from 100-300mcg, administered before sleep.
Dosing Protocols
Conservative: 100mcg before sleep
Standard: 200mcg before sleep
Higher range: 300mcg before sleep
Administration Timing
Evening administration is standard:
- Typically 30-60 minutes before intended sleep time
- Aligns with natural sleep onset
- Allows time for absorption and effect onset
Cycle Duration
Research protocols typically run 2-4 weeks:
- Effects may build over first week
- Assessment period during weeks 2-4
- Break period before repeating
Administration Routes
Subcutaneous: Most common research route with standard peptide injection technique.
Intramuscular: Alternative route used in some studies, may have different absorption kinetics.
Reconstitution Guide
Required Materials
- DSIP lyophilised powder (5mg vial)
- Bacteriostatic water (water containing 0.9% benzyl alcohol)
- Sterile insulin syringe for reconstitution
- Alcohol swabs for sterile technique
Reconstitution Steps
- Allow the DSIP vial to reach room temperature before reconstitution
- Draw 2mL bacteriostatic water into syringe
- Insert the needle into the DSIP vial and direct the stream of water down the inside wall of the vial – do not spray directly onto the powder
- Allow the powder to dissolve naturally without shaking. DSIP typically dissolves readily. The solution should be clear with no visible particles.
- Store reconstituted solution refrigerated at 2-8°C immediately after reconstitution
Concentration Reference Table
| Vial Size | Water Added | Concentration | 100mcg Dose | 200mcg Dose |
|---|---|---|---|---|
| 5mg | 2mL | 2.5mg/mL | 4 units (0.04mL) | 8 units (0.08mL) |
| 5mg | 2.5mL | 2mg/mL | 5 units (0.05mL) | 10 units (0.1mL) |
Storage Guidelines
Lyophilised (Powder) Form
- Long-term storage: -20°C (freezer)
- Short-term storage: 2-8°C (refrigerator)
- Protect from light and moisture
- Stable for extended periods when properly stored
- Keep vial sealed until ready for reconstitution
Reconstituted Solution
- Must be refrigerated at 2-8°C
- Use within 3 weeks (DSIP may be less stable than some peptides)
- Use sterile technique when drawing doses
- Discard if solution becomes cloudy or contains particles
How DSIP Differs From Sleep Medications
DSIP's mechanism differs fundamentally from conventional sleep aids:
| Property | DSIP | Benzodiazepines | Z-Drugs | Melatonin |
|---|---|---|---|---|
| Mechanism | Unknown receptor(s), multiple systems | GABA-A agonism | GABA-A agonism | MT1/MT2 receptors |
| Sedation | Not sedating | Strongly sedating | Sedating | Mildly sedating |
| Natural Sleep | Enhances natural architecture | Disrupts architecture | May disrupt | Supports circadian |
| Dependence | Not reported | Significant risk | Risk present | None |
| Delta Sleep | Promotes | Reduces | May reduce | Minimal effect |
| Stress Hormones | Modulates HPA | No significant effect | No significant effect | Minimal effect |
| Pain Effects | Analgesic | Minimal | Minimal | Minimal |
| Endogenous | Yes (natural peptide) | No | No | Yes |
Unlike sedatives that force sleep by depressing CNS activity, DSIP appears to work with natural sleep mechanisms.
Frequently Asked Questions
Common questions about DSIP research
What is DSIP?
DSIP (Delta Sleep Inducing Peptide) is a 9-amino acid peptide naturally found in the brain and blood. Discovered in 1974, it was named for its ability to promote delta wave (deep) sleep. Research shows effects on sleep, stress hormones, pain perception, and various neuroendocrine functions.
Is DSIP natural?
Yes. DSIP is an endogenous peptide – it occurs naturally in the human body. It is found in the brain and circulates in blood plasma. Concentrations change with sleep-wake cycles and may decrease with age.
Does DSIP cause sedation?
Unlike sedative sleep medications, DSIP does not appear to cause sedation or drowsiness. Research suggests it promotes natural sleep rather than forcing an artificial sleep state. This distinguishes it from benzodiazepines and z-drugs.
How is DSIP different from melatonin?
Both are endogenous and related to sleep, but through different mechanisms. DSIP is a 9-amino acid peptide that promotes delta wave (deep) sleep and affects stress hormones and pain, with an unknown receptor and administered by injection. Melatonin is a hormone that primarily regulates circadian timing, binds MT1/MT2 receptors, has minimal stress/pain effects, and is administered orally.
Does DSIP help with stress?
Research shows DSIP affects the HPA (hypothalamic-pituitary-adrenal) axis, modulating stress hormones including cortisol and ACTH. Studies have examined its effects on chronic stress, though clinical applications are not established.
Can DSIP help with pain?
Research documents analgesic (pain-relieving) properties of DSIP. It may interact with the endogenous opioid system and has been studied in chronic pain contexts. However, clinical pain applications are not established.
Why is DSIP's mechanism unknown?
Despite decades of research, DSIP's receptor(s) have not been definitively identified. It affects multiple systems (sleep, stress, pain, neuroendocrine), suggesting either multiple receptors or a receptor affecting multiple pathways. This remains an active area of research.
Is DSIP approved anywhere?
DSIP is not approved by the FDA, TGA, or major regulatory agencies for any therapeutic use. It has been used in European clinical research settings and was marketed briefly as "Deltaran" in some countries, but does not have widespread pharmaceutical approval.
How should DSIP be stored?
Lyophilised (powder): Freezer (-20°C) for long-term, refrigerator (2-8°C) for short-term. Reconstituted: Refrigerator only, use within 3 weeks.
What is the molecular weight of DSIP?
DSIP has a molecular weight of 848.81 g/mol (Daltons).
The Science: How DSIP Works
The Mystery of DSIP's Mechanism
DSIP is scientifically unusual because, unlike most bioactive peptides, its receptor(s) have not been definitively identified. This creates challenges for mechanistic research but also makes DSIP uniquely interesting.
What We Know
- DSIP produces measurable biological effects
- Effects span multiple systems (sleep, stress, pain, neuroendocrine)
- The peptide crosses the blood-brain barrier
- Effects require the intact peptide (fragments less active)
- Multiple systems seem to be affected
Proposed Explanations
- Novel receptor not yet characterised
- Multiple receptors for different effects
- Indirect effects through known systems
- Modulation of other endogenous peptides
Documented Biological Effects
Sleep Architecture Modulation
Research consistently shows DSIP affects sleep:
- Increases slow-wave (delta) activity on EEG
- Delta waves (0.5-4 Hz) are markers of deep sleep
- N3 sleep is critical for physical restoration
- May improve sleep depth without forcing sleep
HPA Axis and Stress Hormone Modulation
DSIP significantly affects the stress hormone axis:
- CRH: Modulates hypothalamic CRH release, the master regulator of the stress response
- ACTH: Influences pituitary ACTH release and may normalise dysregulated patterns
- Cortisol: Modulates adrenal cortisol output and may help normalise cortisol circadian rhythm
Pain and Opioid System
Research documents analgesic effects:
- May enhance enkephalin activity
- Possible inhibition of enkephalin-degrading enzymes
- Potentiates effects of exogenous opioids
- Increases pain perception thresholds
Blood-Brain Barrier Crossing
Research suggests DSIP crosses the blood-brain barrier:
- Central effects after peripheral administration
- Brain tissue concentrations detected after injection
- Allows systemic administration to affect CNS
DSIP as an Endogenous Peptide
DSIP is found naturally in the body: present in brain tissue (various regions), circulates in blood plasma, found in cerebrospinal fluid, and concentrations change with physiological state.
Circadian Variation
DSIP levels fluctuate – higher during sleep periods, lower during waking – and may participate in natural sleep-wake regulation.
Phosphorylated Forms
A phosphorylated variant (DSIP-P) exists with a different biological activity profile. This may represent regulatory modification and is an active research area.
Amino Acid Sequence and Structure
Full Sequence (Three-Letter Code): Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu
Single-Letter Code: WAGGDASGE
Structural Features
- N-Terminal Tryptophan: Large aromatic amino acid, important for biological activity, may participate in receptor binding, susceptible to oxidation (requires protection)
- Glycine Residues (3, 4, 8): Three glycines provide flexibility and conformational adaptability, may enable binding to unknown receptor
- Acidic Residues (Asp, Glu): Give peptide net negative charge, affect solubility and interactions
- Serine-7: Site of phosphorylation (DSIP to DSIP-P), phosphorylation may regulate activity
Technical Specifications
| Systematic Name | Delta Sleep Inducing Peptide (DSIP) |
|---|---|
| Other Names | Deltaran, Emideltide, Factor S, Delta-Sleep-Inducing Peptide |
| Amino Acid Count | 9 |
| Sequence | WAGGDASGE |
| Molecular Formula | C35H48N10O15 |
| Molecular Weight | 848.81 g/mol |
| CAS Number | 62568-57-4 |
| Isoelectric Point | ~3.5 |
| Net Charge (pH 7) | -2 |
| Appearance | White to off-white lyophilised powder |
| Solubility | Freely soluble in water and aqueous buffers |
| Purity (PurposeLabs) | ≥99% (HPLC verified) |
| Storage (Lyophilised) | -20°C long-term, 2-8°C short-term |
| Storage (Reconstituted) | 2-8°C, use within 4-6 weeks |
Quality: Australian University Testing
Why Peptide Quality Matters
The research peptide market contains products of highly variable quality. Independent testing of products from various suppliers has revealed significant issues:
- Purity levels as low as 50% in products claiming "99% purity"
- Incorrect amino acid sequences (entirely wrong peptides)
- Truncated sequences (missing amino acids)
- Bacterial endotoxin contamination
- Oxidised or degraded peptides with reduced activity
Our Testing Protocol
Every batch of DSIP from PurposeLabs undergoes comprehensive testing at a leading proteomics laboratory based at an Australian university in Sydney – one of Australia's premier analytical facilities.
Confirms purity levels of ≥99%, identifies any impurities or degradation products.
Verifies exact molecular weight, confirms correct amino acid sequence.
Determines actual peptide content versus salt, moisture, and counter-ions.
Why Australian University Testing?
Our testing partner is an established, verifiable proteomics facility at a major Australian university, with published research credentials, transparent methodology, and no commercial conflict of interest. This contrasts with overseas "certificates of analysis" from unknown or unverifiable laboratories.
Shop DSIP
Australian university tested. 99%+ purity verified by HPLC and mass spectrometry. Fast shipping from Sydney.
| Product | Size | Price |
|---|
References
Key studies for researchers seeking primary literature:
- Monnier M, Schoenenberger GA. "Characterization, sequence, synthesis and specificity of a delta-EEG (sleep) inducing peptide." Experientia, 1977.
- Graf MV, Kastin AJ. "Delta-sleep-inducing peptide (DSIP): a review." Neuroscience & Biobehavioral Reviews, 1984.
- Schneider-Helmert D, Schoenenberger GA. "Effects of DSIP in man: multifunctional psychophysiological properties besides induction of natural sleep." Neuropsychobiology, 1983.
- Prudchenko IA, Mikhaleva II. "Current studies of delta-sleep-inducing peptide, its analogues, and the search for the mechanism of action." Neuroscience and Behavioral Physiology, 1994.
- Kovalzon VM, Strekalova TV. "Delta sleep-inducing peptide (DSIP): a still unresolved riddle." Journal of Neurochemistry, 2006.
- Pollard BJ, et al. "Analgesic effects of DSIP in humans." Pain, 1989.
- Shvets-Teneta-Gurii TB. "DSIP and stress tolerance." Bioscience Reports, 1988.
Disclaimer
All products sold by PurposeLabs are intended for laboratory and research use only. They are not intended for human or animal consumption. The information provided is for educational purposes only and should not be construed as medical advice. Consult with qualified healthcare professionals for any health-related decisions.
DSIP is not approved by the TGA for therapeutic use in Australia. Products are sold strictly for research purposes in accordance with Australian regulations.